ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.

Cardiol Ther · 2024 · PMC11607301 · PMID 39455534

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep = 0.12not close (p > 0.1)

The difference in the rate of HF-related hospitalization with valsartan versus amlodipine in the VALUE study also did not reach statistical significance (HR 0.89; 95% CI 0.77, 1.03; p = 0.12) [ 35 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.